Virus Filtration Global Market Report 2024

The global virus filtration market has grown rapidly in recent years. It will grow from $4.88 billion in 2023 to $5.45 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historical period can be attributed to various factors, including an increase in biopharmaceutical production, a rise in the incidence of viral contaminations, the global expansion of biopharmaceutical companies, heightened awareness of viral safety considerations, a focus on monoclonal antibody production, a growing demand for single-use systems, an expansion of biomanufacturing capacities, and the integration of continuous manufacturing processes. These factors collectively contributed to the expansion and development of the biopharmaceutical industry during the specified historical period.

The global virus filtration market is expected to see rapid growth in the next few years. It will grow to $8.71 billion in 2028 at a compound annual growth rate (CAGR) of 12.4%. The anticipated growth in the forecast period can be attributed to various factors, including the growth in vaccine production, heightened preparedness for emerging viral threats, the expansion of cell and gene therapy, an increasing demand for biosimilars, the development of high-throughput systems, a specific focus on point-of-use filtration, continuous improvement in product design, and flexibility in bioprocessing workflows. These factors collectively contribute to the expected expansion of virus filtration applications. Major trends in the forecast period include technological convergence with nanotechnology, the integration of artificial intelligence (AI) in filtration processes, the adoption of sustainable filtration technologies, a shift towards customized filtration solutions, the widespread use of disposable filtration technologies, increased integration of automation, higher investments in research and development (R&D), and a rise in technological partnerships and collaborations. These trends reflect the evolving landscape of virus filtration, incorporating advanced technologies and sustainable practices to meet the changing demands of biopharmaceutical production and viral safety.

The escalation in chronic diseases serves as a significant impetus behind the expansion of the virus filtration market. Chronic illnesses, persisting for a year or longer and often necessitating continual medical attention or impacting daily activities, drive the demand for virus filtration systems. These systems play a pivotal role in averting infectious diseases and chronic conditions by effectively removing viruses, contributing to the market's growth. For instance, statistics from the World Health Organization (WHO) published in September 2022 highlight that noncommunicable diseases (NCDs) lead to approximately 41 million deaths annually, accounting for 74% of global deaths. Among NCDs, cardiovascular diseases claim a significant toll, resulting in 17.9 million deaths annually. The increasing prevalence of cardiovascular conditions is anticipated to further propel the virus filtration market's growth.

The burgeoning demand within the pharmaceutical industry is expected to be a key driver fueling the expansion of the virus filtration market. This sector, responsible for the research, development, manufacturing, and marketing of drugs and treatments, heavily relies on virus filtration in the production of biopharmaceuticals, vaccines, and advanced therapies. The application of virus filtration ensures the delivery of safe, efficacious, and high-quality pharmaceutical products to patients. Reports from IQVIA Inc. in May 2021 projected a substantial rise in total pharmaceutical expenditure in the US, estimated to range between $380 to $400 billion by 2025, indicating a compound annual growth rate of 0-3%. This surge in pharmaceutical demand underlines its role in driving the growth of the virus filtration market.

The upsurge in global research and development (R&D) expenditures is poised to propel the virus filtration market in the forecast period. Governments worldwide are augmenting their R&D budgets to position their countries as advanced scientific hubs. These increased allocations aim to foster innovation in healthcare systems, thereby driving the expansion of virus filtration solutions. For instance, in March 2022, the UK government unveiled its largest-ever R&D budget of £39.8 billion ($47.8 billion) to elevate the nation as a science powerhouse. The budgetary allotments, disbursed across the Department for Business, Energy, and Industrial Strategy’s partner organizations, are expected to rise by 33% annually by 2024-2025. Consequently, the surge in global R&D expenditure is set to drive growth within the virus filtration market.

Technological advancement stands out as a pivotal trend driving innovations within the virus filtration market. Key industry players are intensively focused on developing cutting-edge technological solutions to solidify their market presence and offer enhanced protection against airborne viruses. An illustrative example of this trend is Integrated Viral Protection (IVP), a US-based technology startup that introduced an advanced airborne virus filtration unit at CES 2022, a prominent tech event in Las Vegas, USA. This cutting-edge unit is designed to eradicate airborne viruses, including sub-micron variants causing COVID-19, anthrax spores, and allergens, in a single pass. It leverages IVP's patented 'catch and kill virus' technology, which effectively neutralizes airborne viruses, enhancing safety and mitigation measures against various infectious agents.

Major companies within the virus filtration market are channeling efforts into product innovation, incorporating advanced technology to offer customers reliable solutions. An exemplary product in this vein is the G1 AC Filters, designed for air conditioning systems, providing protection against airborne viruses, bacteria, and fungi. Nanomatrix Materials, an India-based manufacturer specializing in nano and advanced materials, launched the G1 AC Filters in June 2021. These filters boast the ability to eliminate 99% of airborne viruses, bacteria, and particulate matter (PM) 2.5 and above particles, offering defense against black fungus outbreaks. The G1 AC Filters are engineered using Nanomatrix Materials' proprietary graphene-silver nanocomposite technology, ensuring robust virus and bacteria elimination. Designed for compatibility with most air conditioning systems, the filters are user-friendly and easily installable, exemplifying the integration of advanced technology to enhance virus filtration capabilities.

Major companies operating in the virus filtration market report are Merck & Company Inc., GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories International Inc., Sartorius AG, Asahi Kasei Medical Co. Ltd., WuXi AppTec, Danaher Corporation, Sigma-Aldrich Corporation, Clean Cell Inc., Pendotech, Purafil Inc., Qiagen NV, Parker Hannifin Corporation, Eaton Corporation, Freudenberg Group, Entegris Inc., Meissner Filtration Products Inc., Koch Membrane Systems Inc., Graver Technologies LLC, Amazon Filters Ltd., Cobetter Filtration Equipment Co. Ltd., Sterlitech Corporation, Membrane Solutions LLC, Advantec MFS Inc., GVS Group, Porvair Filtration Group, Eaton Filtration LLC

North America was the largest region in the virus filtration market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virus filtration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the virus filtration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main types of virus filtration include kits and reagents, services, filtration systems, and other related categories. Kits are sterile tubing systems designed for the transfer of radioactive proteins between a labeling (reaction) vessel and a purification column, facilitated by peristaltic pumps. Reagents, on the other hand, are substances or compounds that can facilitate a reaction, and they find wide application in various tests. In the context of virus filtration, reagents are integral components of test kits. The use of virus filtration extends across pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Its applications span diverse areas such as medical devices, water purification, air purification, biologicals, vaccines and therapeutics, blood and blood products, as well as cellular and gene therapy products.

This report provides virus filtration market statistics, including virus filtration industry global market size, regional shares, competitors with a virus filtration market share, detailed virus filtration market segments, market trends and opportunities, and any further data you may need to thrive in the virus filtration industry. This virus filtration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The virus filtration market consists of revenues earned by entities by providing virus filtering services to effectively remove viruses in various processes. The market value includes the value of related goods sold by the service provider or included within the service offering. The virus filtration market also includes sales of filters and systems used to remove viruses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.